KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $6.8 million.

  • Evolent Health's Free Cash Flow fell 4467.33% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.7 million, marking a year-over-year decrease of 16266.12%. This contributed to the annual value of -$6.1 million for FY2024, which is 10538.31% down from last year.
  • As of Q3 2025, Evolent Health's Free Cash Flow stood at $6.8 million, which was down 4467.33% from -$39.1 million recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Free Cash Flow peaked at $83.3 million during Q4 2023, and registered a low of -$66.0 million during Q1 2022.
  • Moreover, its 5-year median value for Free Cash Flow was -$438000.0 (2024), whereas its average is $1.9 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 50263.79% in 2023, then plummeted by 82009.13% in 2025.
  • Evolent Health's Free Cash Flow (Quarter) stood at $59.4 million in 2021, then crashed by 58.0% to $25.0 million in 2022, then surged by 233.96% to $83.3 million in 2023, then tumbled by 138.86% to -$32.4 million in 2024, then surged by 121.15% to $6.8 million in 2025.
  • Its last three reported values are $6.8 million in Q3 2025, -$39.1 million for Q2 2025, and -$4.0 million during Q1 2025.